5th Virus Safety Workshop – Next-Gen Biosafety Conference

This year’s theme — “Next-Gen Biosafety: Innovations, Insights, and Industry Standards” — brings together leading experts, regulators, and industry scientists for a focused virus safety conference exploring the technologies and strategies shaping the future of  biosafety testing, NGS-based virus detection, ATMPs and vaccines.

Join us for a face-to-face full-day event that combines:

• in-depth scientific presentations
• real-world implementation case studies
• high-value networking with peers from biologics, vaccines, ATMPs and plasma-derived products

About the Conference

The 5th Virus Safety Workshop is designed as a single-day conference and networking event for professionals working in:

• virus safety and biosafety testing
• biopharmaceutical development and manufacturing
• vaccines and ATMPs
• regulatory affairs, quality and biosafety strategy

Across one intensive day in Vienna, you’ll receive actionable insights, regulatory perspectives and peer benchmarks you can directly apply in your own virus safety programs.

Event Highlights

Session 1: Regulatory Updates – Virus Safety & Biosafety Standards

Understand the latest developments in virus safety regulations and their impact on biosafety strategies across the biopharmaceutical sector.

Session 2: Next-Generation Sequencing (NGS) in Biosafety Testing

Discover how Next-Generation Sequencing (NGS) is transforming pathogen detection and biosafety testing:

• practical NGS case studies for adventitious agent detection
• integration of NGS into virus safety strategies
• lessons learned from early adopters implementing NGS under GMP

Get a clear view of where NGS can replace or complement traditional in vivo and in vitro assays.

Session 3: Platform Technologies & Continuous Manufacturing

Learn how platform technologies and continuous manufacturing are driving safer,
more efficient bioproduction:

• platform-based virus safety strategies
• process validation and viral clearance across multiple products
• how modern biosafety concepts fit into and platform approaches

This session is ideal for teams building platform processes or updating their virus safety
packages to meet current expectations.

Session 4: ATMPs and Vaccines – Virus Safety in Advanced Modalities

Explore virus safety challenges and best practices for Advanced Therapy Medicinal Products (ATMPs) and vaccines:

• virus safety strategies for gene and cell therapies
• specific considerations for vaccine development and manufacturing

If you’re working in ATMPs, gene therapy or vaccines, this session will be especially relevant.

Featured Speakers & Experts

Gain insight from distinguished external speakers and ViruSure specialists, including:

• Johannes Blümel (Paul-Ehrlich-Institut, PEI) – Leading authority on virus safety and regulatory science.
• Martin Spruth (AGES – Austrian Agency for Health and Food Safety) – Expert from Austria’s
  national authority for health, food and pharmaceutical safety.
• Thomas Kreil (Takeda) – Global expert in plasma-derived therapies and viral safety.
• Clara Panosa (HIPRA) – Specialist in vaccine development and biological safety.
• Andy Bailey (CEO, ViruSure) – Co-founder and industry leader in virus safety testing and biosafety strategy.
• Hans-Peter Fasching (ViruSure) – Expert in Next-Generation Sequencing applications for biosafety and adventitious agent detection.

This mix of regulators, industry leaders and CRO specialists makes the 5th Virus Safety Workshop a uniquely practical virus safety conference for decision-makers.

Why Attend This Virus Safety Conference in Vienna?

By joining this year’s full-day conference and workshop, you won’t just hear about next-gen biosafety – you’ll see how it is implemented in real-world settings.

1. See what works in practice

Explore concrete implementation case studies and hear real lessons learned from early adopters of NGS and next-gen biosafety technologies in GMP environments.

2. Stay updated on the latest regulations

Gain early insight into where the regulatory landscape is heading and what you can do now to prepare for future virus safety and biosafety requirements.

3. Ask the questions that matter to you

Use this in-person conference to raise your own questions, challenges and needs directly with regulators, technology leaders and industry strategists.

4. Build collaborations before you need them

Connect with peers from biologics, vaccines, ATMPs and plasma-derived products to spark future projects, partnerships and collaborations.

5. Benchmark against the broader market

Compare your current virus safety strategy with peer and industry practice, and learn from parallel industries also navigating evolving biosafety expectations.

What You’ll Take Home

By the end of this full-day virus safety conference and workshop in Vienna, you’ll have:

• first-hand insight into evolving virus safety and biosafety standards
• a clear view of the technologies reshaping virus safety testing, including NGS
• practical ideas for integrating these approaches into your own programs
• direct connections with the experts and peers actively shaping the future biosafety landscape

We look forward to welcoming you to Vienna for this inspiring, knowledge-rich and highly interactive event — a full-day virus safety and biosafety conference where the future of biosafety takes shape.